New treatment offers potentially promising results for the possibility of slowing, stopping, or even reversing Parkinson’s disease
A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Parkinson’s disease. The study investigated whether boosting the levels of a naturally-occurring growth factor, Glial Cell Line Derived Neurotrophic Factor (GDNF), can regenerate dying dopamine brain cells in patients with Parkinson’s and reverse their condition, something no existing treatment can do. …read more
